Skip to content

Healthcare Access and Utilization Among Living Kidney Donors

Randomized Trial of Financial Incentives to Increase Response Rates to a Mailed Survey of Healthcare Access and Utilization Among Living Kidney Donors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01009125
Enrollment
600
Registered
2009-11-06
Start date
2010-01-31
Completion date
2010-04-30
Last updated
2010-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Organ Donor

Keywords

questionnaires, health care surveys/methods, motivation, living donors, living kidney donation

Brief summary

This is a mailed survey to persons who served as living kidney donors at Saint Barnabas Medical Center. The experimental component of this study (the clinical trial) is a randomized trial of two monetary incentives for the living kidney donors invited to participate in the study. Kidney donors will be randomized to receive one of two incentives in the mailed survey packet: $2 cash vs. $5 cash. The main outcome measure is the response rate to the survey.

Interventions

OTHER$2 cash

$2 cash incentive will be included in the mailed survey

OTHER$5 cash

$5 cash incentive will be included in the mailed survey

Sponsors

St. Barnabas Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Persons who donated a living donor kidney at Saint Barnabas Medical Center between January 2000 and December 2006 are eligible to participate

Exclusion criteria

* Current address outside the continental United States * Persons who donated a living donor kidney prior to January 2000 or after December 2006 * Persons who indicated they no longer wished to be contacted by Saint Barnabas Medical Center

Design outcomes

Primary

MeasureTime frame
Survey response rate2 weeks, 2 months (primary), 4 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026